
|Articles|August 15, 2004
AMO-Pfizer ophthalmic surgical deal final
Santa Ana, CA-Advanced Medical Optics Inc. (AMO) has completed its $450 million cash acquisition of Pfizer Ophthalmics' surgical business.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Eye exams could enable earlier detection of systemic disease
4
FDA approves NDA labeling supplement allowing re-administration of iDose TR
5



























